Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.980
Peer-review started: September 7, 2023
First decision: December 18, 2023
Revised: December 27, 2023
Accepted: January 18, 2024
Article in press: January 18, 2024
Published online: February 16, 2024
Processing time: 146 Days and 3.1 Hours
Microwave endometrial ablation (MEA) is a minimally invasive treatment method for heavy menstrual bleeding. However, additional treatment is often required after recurrence of uterine myomas treated with MEA. Additionally, because this treatment ablates the endometrium, it is not indicated for patients planning to become pregnant. To overcome these issues, we devised a method for ultrasound-guided microwave ablation of uterine myoma feeder vessels. We report three patients successfully treated for heavy menstrual bleeding, secondary to uterine myoma, using our novel method.
All patients had a favorable postoperative course, were discharged within 4 h, and experienced no complications. Further, no postoperative recurrence of heavy menstrual bleeding was noted. Our method also reduced the myoma’s maximum diameter.
This method does not ablate the endometrium, suggesting its potential appli
Core Tip: Ultrasound-guided microwave ablation of the uterine myoma does not ablate the uterine lining, suggesting the possibility of becoming a new treatment for heavy menstrual bleeding due to uterine fibroids for those who wish to conceive in the future.